Precision medicine presents: OXYTOCIN!!!

Published November 7, 2016

Overall, the scientific research examining the efficacy of oxytocin treatment in autism spectrum disorder has been mixed. On a previous podcast, studies on the way the oxytocin receptor was turned on and off were explained, which may account for variability in treatment response. This week, two studies in Japan show that specific mutations in the oxytocin receptor product predict who will respond to oxytocin treatment and who will not. Therefore, the oxytocin story is one of the first examples of using genetic findings to push better treatment on an individual level, otherwise known as precision medicine.

Click here to listen to this week’s podcast from Dr. Alycia Halladay, Chief Science Officer of ASF.

Filed under: Autism, featured, Genetics, Oxytocin, precision medicine